Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

INTERVENTIONAL PAIN MANAGEMENT

NPI: 1710018247 · FLORISSANT, MO 63031 · Interventional Pain Medicine Physician · NPI assigned 03/08/2007

$215K
Total Medicaid Paid
14,888
Total Claims
12,016
Beneficiaries
19
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialGUNAPOOTI, MAHENDRA (PRESIDENT)
NPI Enumeration Date03/08/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,387 $33K
2019 1,602 $20K
2020 1,458 $17K
2021 2,167 $37K
2022 1,689 $27K
2023 3,219 $43K
2024 2,366 $37K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
64483 1,263 1,067 $60K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,147 2,597 $58K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,555 2,857 $37K
64484 659 559 $13K
93923 923 365 $10K
95924 453 360 $7K
95923 462 361 $6K
72275 319 290 $5K
64493 165 134 $5K
64479 66 50 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,045 886 $3K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 132 78 $2K
64494 132 104 $2K
J1030 Injection, methylprednisolone acetate, 40 mg 1,557 1,420 $2K
93040 445 349 $789.13
64490 12 12 $446.84
64480 13 12 $427.22
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 455 433 $228.14
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 85 82 $162.31